ARCO
Arcos Dorados Holdings Inc.
ARCO has the edge over LCID overall, supported by stronger valuation and lower modeled downside.
LCID
Lucid Group, Inc.
LCID offers stronger modeled upside, but that advantage does not outweigh its weaker overall profile.
ARCO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Stable | |
| Under pressure |
ARCO's revenue and profitability are currently healthy, and its cash flow is stable, but its balance sheet is under pressure.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
ARCO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 5.8x | $7.00 | — |
| Cheap | 7.8x | $9.45 | +35% |
| Fair | 11x | $13.88 | +98% |
| Expensive | 19x | $23.55 | +236% |
Historical ranges are pointers, not guarantees.
ARCO's PE is in its cheap range at 5.8x.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
ARCO Forward outlook
There aren't enough analyst estimates for ARCO to show an outlook.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
ARCO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $1.21 | +92% |
| Q1 2026 | $1.11 | +71% |
| Q4 2025 | $1.01 | +40% |
| Q3 2025 | $1.17 | +67% |
| Q2 2025 | $0.63 | -44% |
| Q1 2025 | $0.65 | -42% |
| Q4 2024 | $0.72 | -38% |
| Q3 2024 | $0.70 | -40% |
ARCO has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
ARCO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $1.3B | +14% |
| Q1 2026 | $1.2B | +13% |
| Q4 2025 | $1.3B | +11% |
| Q3 2025 | $1.2B | +5.2% |
| Q2 2025 | $1.1B | +2.8% |
| Q1 2025 | $1.1B | -0.4% |
| Q4 2024 | $1.1B | -2.7% |
| Q3 2024 | $1.1B | +0.8% |
ARCO's revenue has grown year over year for five quarters in a row: $1.3B last quarter, up 14% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 5.9% | +0.4 points |
| Q1 2026 | 4.7% | +0.5 points |
| Q4 2025 | 7.5% | -1.5 points |
| Q3 2025 | 12% | +5.3 points |
| Q2 2025 | 5.5% | -1.2 points |
| Q1 2025 | 4.2% | -2.1 points |
| Q4 2024 | 9% | +2 points |
| Q3 2024 | 7% | -1 points |
ARCO has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over ARCO on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
ARCO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $56.4M | +257% |
| Q1 2026 | -$18.7M | +$43.5M |
| Q4 2025 | $27.2M | +46% |
| Q3 2025 | $30.4M | +421% |
| Q2 2025 | $15.8M | +$30.4M |
| Q1 2025 | -$62.2M | +$8.4M |
| Q4 2024 | $18.6M | +65% |
| Q3 2024 | $5.8M | -87% |
ARCO has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
ARCO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 3.0x | Elevated |
| Q1 2026 | 3.1x | Elevated |
| Q4 2025 | 3.2x | Elevated |
| Q3 2025 | 3.3x | Elevated |
| Q2 2025 | 4.0x | Elevated |
| Q1 2025 | 3.8x | Elevated |
| Q4 2024 | 3.3x | Elevated |
| Q3 2024 | 3.4x | Elevated |
ARCO's net debt is about 3.0 years of its operating earnings (EBITDA), down from 4.0 years a year ago.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
ARCO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.2 | Neutral |
| Stochastic | 12.7 | Oversold |
ARCO's weekly RSI is 40 (neutral) and its Stochastic is 13 (oversold).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
ARCO PE vs Consumer Cyclical Sector
| Metric | ARCO | Sector median | Relative |
|---|---|---|---|
| PE | 5.8x | 18x | 68% below |
| PE % | 1 | 47 | 46 pts below |
ARCO is trading at 5.8x earnings, a 68% discount to the Consumer Cyclical sector's median of 18x.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
ARCO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $7.36 | 4.9% below |
| 20 week MA | $7.80 | 10% below |
| 50 week MA | $8.05 | 13% below |
| 100 week MA | $7.74 | 9.6% below |
| 200 week MA | $8.75 | 20% below |
ARCO is in a downtrend: it's below all five of its weekly moving averages, and 20% below its 200-week average.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
ARCO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $8.18 | $4.93 | -40% |
| 2021 | $4.93 | $5.33 | +8.1% |
| 2022 | $5.33 | $8.32 | +56% |
| 2023 | $8.32 | $12.7 | +53% |
| 2024 | $12.7 | $7.29 | -43% |
| 2025 | $7.29 | $7.37 | +1.1% |
| 2026 YTD | $7.37 | $7.00 | -5% |
ARCO has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.